Spring Bank Pharmaceuticals, Inc. (38) | Business Finance (9)

Browse by Subcategory

Recent Contracts

Side Letter, dated June 30, 2021, to (a) the License and Collaboration Agreement, dated August 24, 2016, by and among BBB Holding Ltd (f/k/a F-star Gamma Limited, DBH ), F-star... (Filed With SEC on August 13, 2021)
Form of Warrant issued under the Venture Loan and Security Agreement, dated April 1, 2021 (Filed With SEC on May 17, 2021)
Underwriting Agreement, dated May 6, 2021, between F-star Therapeutics, Inc. and SVB Leerink LLC (Filed With SEC on May 10, 2021)
STING Agonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare Inc.,... (Filed With SEC on November 20, 2020)
Form of Restricted Stock Unit Agreement (Filed With SEC on May 7, 2020)
Form of Amended and Restated Warrant (Filed With SEC on April 13, 2020)
Venture Loan and Security Agreement, dated April 1, 2021, by and among F-star Therapeutics, Inc., as borrower, F-star Therapeutics Limited, as guarantor, and Horizon Technology... (Filed With SEC on May 17, 2021)
STING Antagonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare... (Filed With SEC on November 20, 2020)
Loan and Security Agreement, dated September 3, 2019 (Filed With SEC on September 4, 2019)